“Breaking News: ESSA Pharma Inc. Faces Legal Action for Alleged Securities Law Violations”

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against ESSA Pharma Inc.

LOS ANGELES, CA / ACCESS Newswire / January 31, 2025

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ESSA Pharma Inc. (“ESSA” or “the Company”) (NASDAQ:EPIX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s

Leave a Reply